KRBP logo

Kiromic BioPharma (KRBP) Free Cash Flow

KRBP Annual FCF

-$21.43 M
+$7.19 M+25.13%

31 December 2023

KRBP Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP Quarterly FCF

-$2.15 M
+$6.13 M+74.03%

30 September 2024

KRBP Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP TTM FCF

-$21.67 M
+$3.17 M+12.78%

30 September 2024

KRBP TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KRBP Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.1%+74.0%+12.8%
3 y3 years-182.6%+66.7%-4.6%
5 y5 years-835.8%+66.7%-4.6%

KRBP Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.1%at high+79.0%-7.9%+37.6%
5 y5-year-566.3%+25.1%-78.5%+79.0%-573.6%+37.6%
alltimeall time-835.8%+25.1%-1171.4%+79.0%-8521.5%+37.6%

Kiromic BioPharma Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$2.15 M(-74.0%)
-$21.67 M(-12.8%)
June 2024
-
-$8.28 M(+44.7%)
-$24.84 M(+7.9%)
Mar 2024
-
-$5.72 M(+3.7%)
-$23.02 M(+7.4%)
Dec 2023
-$21.43 M(-25.1%)
-$5.52 M(+3.6%)
-$21.43 M(+6.8%)
Sept 2023
-
-$5.33 M(-17.6%)
-$20.07 M(-3.1%)
June 2023
-
-$6.46 M(+56.5%)
-$20.71 M(-8.7%)
Mar 2023
-
-$4.13 M(-0.8%)
-$22.69 M(-20.7%)
Dec 2022
-$28.63 M(+28.9%)
-$4.16 M(-30.2%)
-$28.63 M(-17.6%)
Sept 2022
-
-$5.96 M(-29.4%)
-$34.73 M(+2.8%)
June 2022
-
-$8.44 M(-16.1%)
-$33.79 M(+14.1%)
Mar 2022
-
-$10.06 M(-2.0%)
-$29.60 M(+33.2%)
Dec 2021
-$22.22 M
-$10.26 M(+104.5%)
-$22.22 M(+48.4%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$5.02 M(+18.0%)
-$14.97 M(+34.2%)
June 2021
-
-$4.25 M(+58.7%)
-$11.15 M(+33.1%)
Mar 2021
-
-$2.68 M(-11.1%)
-$8.38 M(+10.5%)
Dec 2020
-$7.58 M(+135.8%)
-$3.01 M(+150.3%)
-$7.58 M(+12.2%)
Sept 2020
-
-$1.20 M(-18.6%)
-$6.76 M(+9.7%)
June 2020
-
-$1.48 M(-21.6%)
-$6.16 M(+27.0%)
Mar 2020
-
-$1.89 M(-13.8%)
-$4.85 M(+50.8%)
Dec 2019
-$3.22 M(+40.5%)
-$2.19 M(+260.7%)
-$3.22 M(+213.1%)
Sept 2019
-
-$607.00 K(+259.0%)
-$1.03 M(+144.4%)
June 2019
-
-$169.10 K(-32.7%)
-$420.40 K(+67.3%)
Mar 2019
-
-$251.30 K
-$251.30 K
Dec 2018
-$2.29 M
-
-

FAQ

  • What is Kiromic BioPharma annual free cash flow?
  • What is the all time high annual FCF for Kiromic BioPharma?
  • What is Kiromic BioPharma annual FCF year-on-year change?
  • What is Kiromic BioPharma quarterly free cash flow?
  • What is the all time high quarterly FCF for Kiromic BioPharma?
  • What is Kiromic BioPharma quarterly FCF year-on-year change?
  • What is Kiromic BioPharma TTM free cash flow?
  • What is the all time high TTM FCF for Kiromic BioPharma?
  • What is Kiromic BioPharma TTM FCF year-on-year change?

What is Kiromic BioPharma annual free cash flow?

The current annual FCF of KRBP is -$21.43 M

What is the all time high annual FCF for Kiromic BioPharma?

Kiromic BioPharma all-time high annual free cash flow is -$2.29 M

What is Kiromic BioPharma annual FCF year-on-year change?

Over the past year, KRBP annual free cash flow has changed by +$7.19 M (+25.13%)

What is Kiromic BioPharma quarterly free cash flow?

The current quarterly FCF of KRBP is -$2.15 M

What is the all time high quarterly FCF for Kiromic BioPharma?

Kiromic BioPharma all-time high quarterly free cash flow is -$169.10 K

What is Kiromic BioPharma quarterly FCF year-on-year change?

Over the past year, KRBP quarterly free cash flow has changed by +$6.13 M (+74.03%)

What is Kiromic BioPharma TTM free cash flow?

The current TTM FCF of KRBP is -$21.67 M

What is the all time high TTM FCF for Kiromic BioPharma?

Kiromic BioPharma all-time high TTM free cash flow is -$251.30 K

What is Kiromic BioPharma TTM FCF year-on-year change?

Over the past year, KRBP TTM free cash flow has changed by +$3.17 M (+12.78%)